GlaxoSmithKline - 33 Year Stock Price History | GSK

Historical daily share price chart and data for GlaxoSmithKline since 1986 adjusted for splits. The latest closing stock price for GlaxoSmithKline as of October 16, 2019 is 42.28.
  • The all-time high GlaxoSmithKline stock closing price was 75.56 on January 06, 1999.
  • The GlaxoSmithKline 52-week high stock price is 43.22, which is 2.2% above the current share price.
  • The GlaxoSmithKline 52-week low stock price is 36.41, which is 13.9% below the current share price.
  • The average GlaxoSmithKline stock price for the last 52 weeks is 40.30.
GlaxoSmithKline Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 40.5276 37.8800 42.6800 37.8300 42.2800 10.65%
2018 39.4178 36.9300 41.9400 35.4900 38.2100 7.72%
2017 40.1910 38.8400 44.3700 34.6600 35.4700 -7.89%
2016 41.3668 40.4500 45.4900 37.3900 38.5100 -4.56%
2015 43.2943 42.3700 48.8100 37.5600 40.3500 -5.59%
2014 50.4502 52.7900 56.6600 41.3000 42.7400 -19.95%
2013 49.8600 44.1300 53.6800 43.9300 53.3900 22.82%
2012 45.1876 46.2800 47.4500 41.9000 43.4700 -4.73%
2011 41.6481 39.2500 45.7400 36.3300 45.6300 16.34%
2010 38.0994 42.9700 42.9700 32.3400 39.2200 -7.17%
2009 36.4059 36.9700 42.9100 27.2700 42.2500 13.36%
2008 43.1393 50.1700 54.3600 32.0200 37.2700 -26.04%
2007 53.5075 53.8100 59.3500 47.8700 50.3900 -4.49%
2006 53.8180 50.9600 58.3800 50.1500 52.7600 4.52%
2005 48.8547 47.3500 53.5300 44.4800 50.4800 6.52%
2004 42.4878 46.8300 47.5000 39.0400 47.3900 1.65%
2003 40.4859 38.5100 47.4000 32.7500 46.6200 24.45%
2002 42.6481 49.8500 50.8700 32.8600 37.4600 -24.81%
2001 53.7163 55.8800 57.7600 48.8000 49.8200 -11.04%
2000 56.4862 55.5600 63.7500 46.0000 56.0000 0.21%
1999 59.1138 70.9400 75.5600 49.0600 55.8800 -19.60%
1998 58.5289 48.1300 69.5000 48.1300 69.5000 45.15%
1997 39.8858 31.3700 48.0000 30.1200 47.8800 50.80%
1996 28.0910 28.1200 34.0000 23.3700 31.7500 12.91%
1995 23.7419 20.8700 28.1200 19.0000 28.1200 38.05%
1994 18.6191 21.1200 21.3700 16.0000 20.3700 -2.40%
1993 18.8516 23.8700 23.8700 14.8800 20.8700 -12.13%
1992 27.2174 31.8700 34.7500 22.2500 23.7500 -25.20%
1991 22.1012 16.4400 31.7500 15.5600 31.7500 93.89%
1990 14.0987 12.8750 17.3150 11.4350 16.3750 25.96%
1989 11.4286 9.6250 13.1850 9.2500 13.0000 35.06%
1988 9.0362 9.4350 10.1850 8.0000 9.6250 5.48%
1987 11.9627 7.6900 15.1850 7.6900 9.1250 18.66%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $105.181B $41.140B
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $344.992B 15.02
Roche Holding AG (RHHBY) Switzerland $246.683B 0.00
Merck (MRK) United States $216.838B 17.83
Pfizer (PFE) United States $200.777B 11.82
Novartis AG (NVS) Switzerland $196.934B 16.95
Novo Nordisk (NVO) Denmark $123.207B 21.77
AstraZeneca (AZN) United Kingdom $115.026B 22.25
Sanofi (SNY) France $112.411B 13.81
AbbVie (ABBV) United States $109.053B 8.74
Eli Lilly (LLY) United States $104.170B 19.44
Bristol-Myers Squibb (BMY) United States $84.340B 11.96
Bayer (BAYRY) Germany $67.293B 9.80
H Lundbeck (HLUYY) Denmark $6.598B 9.52